Navigation Links
Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
Date:1/7/2008

- Company on Target to File NDA in Second Quarter of 2008 -

CORONA, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced positive results today from its Phase 3 study of oxybutynin topical gel (OTG) in patients with overactive bladder (OAB). The study met its primary endpoint of a statistically significant reduction in incontinence episodes, and secondary endpoints of reduction in frequency and increases in void volume compared with placebo, while demonstrating a low incidence of side effects.

"We are extremely encouraged with the results from this trial which will support our NDA submission, and we are on track to file with FDA in the second quarter of 2008," said Paul Bisaro, Watson's President and Chief Executive Officer. "Additionally, we have the potential to introduce the first gel formulation for the treatment of overactive bladder in 2009."

"Offering patients the ease and comfort of a daily gel for the treatment of OAB may provide greater patient acceptability and persistence on treatment," said Peter K. Sand, M.D., director of the Evanston Continence Center, Evanston Northwestern Healthcare, Northwestern University, Feinberg School of Medicine and Professor of Obstetrics and Gynecology and Director of the Division of Urogynecology, Evanston, IL.

It is well recognized that transdermal delivery of oxybutynin is a safe and effective treatment for OAB. By delivering oxybutynin transdermally, first-pass gastric and hepatic metabolism is bypassed, which is believed to result in lower anticholinergic side effects such as dry mouth and constipation. These side effects result in a significant level of patient non-compliance a
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
5. Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF
6. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
9. QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
10. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma
11. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... YORK , March 31, 2015 Immune ... announced today that it intends to expand its planned ... human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is an ... 60,000 patients in the US and Europe ... to start enrolling patients in a Phase II clinical ...
(Date:3/31/2015)...  CVS Health (NYSE: CVS ) announced ... with Rush University Medical Center in ... in Tucson, Arizona and ... affiliations will help enhance access to high-quality, affordable ... affiliations, CVS Health will provide prescription and visit ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... addition of the "European Laboratory Information System ... by Type (Clinical Pathology Laboratory Information System, Anatomic ... report to their offering. The ... grow at a CAGR of 7.6% from 2014 ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 2CVS Health Announces New Clinical Affiliations with Leading Medical Centers in Arizona and Illinois 3European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3
(Date:3/31/2015)... 2015 Cosmetic Town, one of the ... proudly enduring adding news to its site while it ... of plastic surgery and cosmetic medicine better use and ... interconnected sections, the Cosmetic Town community is tingling at ... Cosmetic Town site navigation, News and Blog section, will ...
(Date:3/31/2015)... Karen A. Daley, Ph.D. will address ... University’s Commencement ceremony on May 9, 2015 and ... recognition of her eminent career as a nurse, public ... caregiver and senior staff nurse at Brigham and Women’s ... leadership roles, including President of the American Nurses Association ...
(Date:3/31/2015)... Indosoft, developer of the Q-Suite call center software ... of their 5.x line. The industry leading contact center ... the world for more than a decade. By announcing an ... Q-Suite can fully embrace newer Asterisk features and improve performance. ... Asterisk for more than a decade. The use of Asterisk, ...
(Date:3/31/2015)... CA (PRWEB) March 31, 2015 ... joins BayBio’s Membership Program , the premiere ... the region’s 1300+ life science companies. , ... of the world’s most innovative and productive life ... to solve some of humanity’s most pressing challenges. ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Healthpointe’s team ... injuries at all of their clinics. Specialties include hip ... , For athletes with hip injuries, Healthpointe has ... assess and treat the symptoms and underlying causes of ... minimally-invasive care and prevent future damage, while taking into ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town is Now Transforming so Consumer can Better Navigate 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 2Health News:Rivier University to recognize nurse leader, educator and safety advocate at 80th Commencement on May 9th 3Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:Clinovo Joins BayBio Membership Program, The Leading Life Science Association in Northern California 2Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2
... Status in Providing Healthcare Technology Consulting , , HATBORO, ... (Nasdaq: IFLG ), a leading technology provider of ... today that the company has been ranked by Healthcare Informatics ... companies in healthcare IT based on total annual ...
... and mosquito bites, , TUESDAY, June 23 (HealthDay News) -- ... picnicking in grassy fields and camping in the woods. , ... the American College of Emergency Physicians. But keep in mind ... getting bitten by mosquitoes and ticks. , "The bite itself ...
... says, , TUESDAY, June 23 (HealthDay News) -- Scientists have ... sarcoma disproportionately strikes white people. , What,s more, among whites ... from it than females, according to a study published online ... Sean Scully of the University of Miami, the researchers analyzed ...
... According to a new report from the U.S. Preventive Services ... depression. The group said that all 12- to 18-year-olds should ... depression and suicidal tendencies. While there is a great deal ... and emotional health of children does not receive nearly as ...
... 23 The Certification Commission for Healthcare Information Technology ... Certified(R) 08 Ambulatory EHR, and meets 100% of 2008 ... of approval" for EHR products provides a consensus-based, government-recognized ... with the CCHIT Certified(R) seal, physicians and other providers ...
... released today by the Association for Psychological Science: , , ... 65; in 2000 that number had jumped to 12.6 percent; and ... in that category. , , Cognitive decline was long ... seen a surge of interest in activities and products touted to ...
Cached Medicine News:Health News:InfoLogix Ranked as 7th Leading Consulting Company in Healthcare IT 2Health News:InfoLogix Ranked as 7th Leading Consulting Company in Healthcare IT 3Health News:In Summertime, the Livin' Can Be Buggy 2Health News:In Summertime, the Livin' Can Be Buggy 3Health News:Whites More Likely to Get Rare Bone Cancer 2Health News:Should All Kids Be Screened for Depression? This Expert Says Yes and Explains How It Can Save Lives 2Health News:The Criterions Medical Suite EHR 1.0.0 Receives 08 CCHIT Certification 2Health News:The Criterions Medical Suite EHR 1.0.0 Receives 08 CCHIT Certification 3Health News:Major New Report Establishes Effective Methods of Enhancing and Preserving Brain Power as We Age 2Health News:Major New Report Establishes Effective Methods of Enhancing and Preserving Brain Power as We Age 3
... a concise yet complete eTextbook of ... cardiovascular disease. In addition to the ... a full desktop version is included ... to the electronic textbook, Redi-Reference provides ...
ECG pocket is a handy reference for identifying common ECG findings....
... Reviews enable all those involved with healthcare ... the very latest evidence in their field ... harder each year as the volume of ... by delivering the best single source available ...
... Anatomy Flash Cards is ... the heart, veins, and ... system. It uses the ... images from BryanEdwards.com and ...
Medicine Products: